Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (BCBA:EDN)

G1 Therapeutics Balance Sheet

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59,237	23,918	19,877	11,054	6,179	6,582
Short-Term Investments	854	19,144	44,436	-	474	117
Trading Asset Securities	327,386	363,351	179,933	194,635	30,097	3,352
Accounts Receivable	467,259	362,367	145,024	189,818	34,212	21,352
Other Receivables	45,279	37,219	22,546	126,808	2,822	590
Inventory	190,259	149,772	86,704	43,657	6,702	2,823
Prepaid Expenses	-	3,839	1,954	-	-	64
Other Current Assets	-	6,654	5,204	-	1,332	287
Total Current Assets	1,090,274	966,264	505,678	565,972	81,818	35,167
Property, Plant & Equipment	3,543,974	3,013,068	2,779,819	2,689,827	381,409	188,822
Long-Term Investments	17,509	121	124	144	27	378
Other Long-Term Assets	12,591	124	6	20	14	143
Total Assets	4,664,348	3,979,577	3,285,627	3,255,963	463,268	224,510
Accounts Payable	656,023	613,053	425,270	1,219,334	128,878	39,145
Accrued Expenses	96,643	96,672	68,993	73,854	10,100	8,215
Short-Term Debt	-	55,469	618	-	-	-
Current Portion of Long-Term Debt	126,690	57,061	109,708	1,248	19,989	216
Current Unearned Revenue	641	3,267	2,805	298	1,023	677
Current Portion of Leases	-	3,877	4,706	-	522	217
Current Income Taxes Payable	69,391	-	-	-	2,442	-
Other Current Liabilities	148,125	260,383	162,540	53,060	27,001	15,154
Total Current Liabilities	1,097,513	1,089,782	774,640	1,347,794	189,955	63,624
Long-Term Debt	419,069	354,945	96,566	98,577	-	12,465
Long-Term Leases	-	5,010	1,636	-	154	92
Long-Term Unearned Revenue	123,879	108,131	29,342	24,936	3,287	2,220
Pension & Post-Retirement Benefits	17,203	13,648	10,719	12,619	1,941	1,167
Long-Term Deferred Tax Liabilities	739,508	687,790	765,391	561,142	96,303	35,774
Other Long-Term Liabilities	401,585	213,206	374,729	167,720	28,078	14,266
Total Liabilities	2,798,757	2,472,512	2,053,023	2,212,788	319,718	129,608
Common Stock	875	875	875	875	875	875
Additional Paid-In Capital	11,888	10,329	10,269	10,178	1,492	760
Retained Earnings	1,055,979	803,654	531,526	340,139	39,463	41,603
Treasury Stock	-70,036	-60,856	-60,856	-60,856	-8,974	-4,607
Comprehensive Income & Other	866,885	753,063	750,790	752,839	110,694	56,271
Shareholders' Equity	1,865,591	1,507,065	1,232,604	1,043,175	143,550	94,902
Total Liabilities & Equity	4,664,348	3,979,577	3,285,627	3,255,963	463,268	224,510
Total Debt	545,759	476,362	213,234	99,825	20,665	12,990
Net Cash (Debt)	-158,282	-69,949	31,012	105,864	16,085	-2,939
Net Cash Growth	-	-	-70.71%	558.15%	-	-
Net Cash Per Share	-180.89	-79.94	35.44	120.99	18.38	-3.36
Filing Date Shares Outstanding	875.68	875.68	875.6	875.46	875.32	875.07
Total Common Shares Outstanding	875.68	875.68	875.6	875.46	875.32	875.07
Working Capital	-7,239	-123,518	-268,962	-781,822	-108,137	-28,457
Book Value Per Share	2130.44	1721.02	1407.72	1191.57	164.00	108.45
Tangible Book Value	1,865,591	1,507,065	1,232,604	1,043,175	143,550	94,902
Tangible Book Value Per Share	2130.44	1721.02	1407.72	1191.57	164.00	108.45
Land	-	81,391	79,846	75,297	11,060	5,498
Machinery	-	1,871,877	1,775,148	1,674,666	229,987	109,810
Construction In Progress	-	901,590	708,551	609,146	84,965	42,313

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.